The effects of pioglitazone vs metformin on depression and hormonal changes in polycystic ovarian syndrome : a randomized clinical trial.

Trial Profile

The effects of pioglitazone vs metformin on depression and hormonal changes in polycystic ovarian syndrome : a randomized clinical trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2013

At a glance

  • Drugs Pioglitazone (Primary) ; Metformin
  • Indications Major depressive disorder; Polycystic ovary syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Aug 2013 Status changed from recruiting to completed.
    • 01 Jun 2013 Primary endpoint 'Hamilton-Depression-Rating-Scale' has been met.
    • 01 Oct 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top